Shares of Cyclerion Therapeutics, Inc. (NASDAQ:CYCN – Get Free Report) traded up 2.8% during trading on Wednesday . The company traded as high as $3.00 and last traded at $2.92. 19,426 shares changed hands during trading, an increase of 299% from the average session volume of 4,872 shares. The stock had previously closed at $2.84.
Cyclerion Therapeutics Trading Up 2.8 %
The business’s fifty day moving average is $2.77 and its 200 day moving average is $2.84.
Cyclerion Therapeutics (NASDAQ:CYCN – Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The company reported ($0.53) EPS for the quarter.
About Cyclerion Therapeutics
Cyclerion Therapeutics, Inc, a biopharmaceutical company, develops treatments for serious diseases. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to out-license for cardiovascular diseases; and Praliciguat, a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc for the treatment of rare kidney disease.
Featured Articles
- Five stocks we like better than Cyclerion Therapeutics
- 3 Warren Buffett Stocks to Buy Now
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- The How And Why of Investing in Oil Stocks
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Stock Sentiment Analysis: How it Works
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Cyclerion Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclerion Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
